Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Stanley Manne Children's Research Institute, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Am J Transplant. 2021 Jan;21(1):344-352. doi: 10.1111/ajt.16070. Epub 2020 Jul 8.
Molecular mismatch analysis for assessment of histocompatibility in transplantation requires high-resolution HLA typing. Algorithms to "guesstimate" high-resolution from low-resolution typing exist, but their accuracy remains unknown. We converted high-resolution, sequence-based, HLA typing of 310 subjects from an ethnically heterogeneous population to low-resolution equivalents and tested the ability of the NMDP HaploStats and HLA Matchmaker programs to impute/reproduce the measured high-resolution HLA type, using the more common "winner-takes-all" approach. Only 35.6% of the HaploStats imputed HLA-A, -B, -C, -DRB1, and -DQB1 haplotypes had no mistakes, and the accuracy was significantly lower for non-Caucasians (29.1%) compared to Caucasians (45.2%) (odds ratio [OR], 0.5; 95% confidence interval [CI], 0.3-0.8; P = .004). HLA Matchmaker was not able to provide high-resolution haplotypes for 45.2% of Caucasian subjects and 63.5% of non-Caucasian subjects (P = .002). Of those with an imputed result, only 10.3% of Caucasians and 4.8% of non-Caucasians had accurate 10-allele high-resolution output. Eplet analysis revealed additional, inaccurate eplets in 37% of individuals, with 22.5% showing at least 2 additional, inaccurate eplets; incorrect eplets were more common among non-Caucasians (OR, 1.8; 95% CI, 1.1-2.9; P = .018). Given this high error rate, caution should be taken before using imputation tools for clinical or research purposes, especially for non-Caucasian individuals.
分子错配分析用于评估移植中的组织相容性需要高分辨率 HLA 分型。存在用于“猜测”低分辨率 HLA 分型的高分辨率 HLA 分型的算法,但它们的准确性仍不清楚。我们将来自种族多样化人群的 310 名受检者的高分辨率、基于序列的 HLA 分型转换为低分辨率等效物,并使用更为常见的“胜者全得”方法,测试 NMDP HaploStats 和 HLA Matchmaker 程序推断/重现测量的高分辨率 HLA 型的能力。只有 35.6%的 HaploStats 推断的 HLA-A、-B、-C、-DRB1 和-DQB1 单体型没有错误,非白种人(29.1%)的准确性明显低于白种人(45.2%)(比值比[OR],0.5;95%置信区间[CI],0.3-0.8;P=0.004)。HLA Matchmaker 无法为 45.2%的白种人和 63.5%的非白种人提供高分辨率单体型(P=0.002)。在有推断结果的人群中,只有 10.3%的白种人和 4.8%的非白种人具有准确的 10 个等位基因高分辨率输出。表位分析显示,37%的个体中存在额外的不准确表位,其中 22.5%显示至少 2 个额外的不准确表位;非白种人更容易出现不正确的表位(OR,1.8;95%CI,1.1-2.9;P=0.018)。鉴于这种高错误率,在出于临床或研究目的使用推断工具时应谨慎,特别是对于非白种人。